Deferred Tax Assets, Valuation Allowance of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $235,293,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $235,293,000 +$53,688,000 +30% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $181,605,000 +$58,153,000 +47% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $123,452,000 +$111,886,000 +967% 31 Dec 2023 10-K 09 Mar 2026 2025 FY
Q4 2022 $11,566,000 +$6,372,000 +123% 31 Dec 2022 10-K 11 Mar 2025 2024 FY
Q4 2021 $5,194,000 +$3,887,000 +297% 31 Dec 2021 10-K 21 Mar 2024 2023 FY
Q4 2020 $1,307,000 -$50,941,000 -97% 31 Dec 2020 8-K 21 Dec 2023
Q4 2019 $52,248,000 +$23,005,000 +79% 31 Dec 2019 10-K 08 Mar 2022 2021 FY
Q4 2018 $29,243,000 +$16,777,000 +135% 31 Dec 2018 10-K 03 Mar 2021 2020 FY
Q4 2017 $12,466,000 +$8,926,000 +252% 31 Dec 2017 10-K 03 Mar 2020 2019 FY
Q4 2016 $3,540,000 +$3,411,000 +2644% 31 Dec 2016 10-K 03 Mar 2020 2019 FY
Q4 2015 $129,000 31 Dec 2015 10-K 19 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.